AKT1 and liver cancer: The AKT/mTOR pathway is a well‐studied anticancer pathway,10 and the PI3K/AKT/m TOR pathway has been found to be overactivated in liver cancer, cell survival, proliferation, migration, apoptosis, tumor metastasis, angiogenesis, and transformation.11